Form 4 for RYTM RHYTHM PHARMACEUTICALS, INC.
Accepted 2026-02-03 00:00:00 ET · period of report 2026-02-01 · accession 0001104659-26-009766 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-03 | 2026-02-01 | RYTM | German Christopher Paul | CAO, Corp. Ctrl | M - OptEx | — | +3,613 | 4,571 | +377% | — |
| D | 2026-02-03 | 2026-02-01 | RYTM | German Christopher Paul | CAO, Corp. Ctrl | F - Tax | $108.99 | -1,138 | 3,433 | -25% | -$124.0K |
| DM | 2026-02-03 | 2026-02-01 | RYTM | German Christopher Paul | CAO, Corp. Ctrl | M - OptEx | $0.00 | -3,613 | 5,418 | -40% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-01 | M | A | 3,613 | — | 4,571 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. (F2) Includes 36 shares of Common Stock purchased pursuant to the Rhythm Pharmaceuticals, Inc. Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2026-02-01 | F | D | 1,138 | $108.99 | 3,433 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2026-02-01 | M | D | 1,806 | $0.00 | 3,612 | D | — · — to — | 1,806 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. (F4) The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 1, 2026, February 1, 2027 and February 1, 2028. The restricted stock units have no expiration date. |
| 4 | Derivative | Restricted Stock Units | 2026-02-01 | M | D | 1,807 | $0.00 | 5,418 | D | — · — to — | 1,807 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. (F5) The restricted stock units vest as to 25% of the total shares on each of February 1, 2026, February 1, 2027, February 1, 2028 and February 1, 2029. The restricted stock units have no expiration date. |